Akari Therapeutics (AKTX) EBITDA (2014 - 2026)
Akari Therapeutics (AKTX) posted EBITDA of -$14.4 million for Q1 2026, down 192.56% sequentially from -$4.9 million in Q4 2025, and down 286.12% YoY from $7.8 million in Q1 2025.
Akari Therapeutics (AKTX) EBITDA (2014 - 2026) Analysis & Trends
Akari Therapeutics (AKTX) has 10 years of EBITDA data on file, last reported at -$14.4 million in Q1 2026.
- Quarterly EBITDA fell 286.12% year-over-year to -$14.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$28.0 million (down 56.3% YoY) and the FY2025 annual result came in at -$17.3 million, up 11.02% from the prior year.
- EBITDA declined to -$14.4 million in Q1 2026 per AKTX's latest filing, from -$4.9 million in the prior quarter.
- The five-year high for EBITDA was $1.0 million in Q1 2023, with the low at -$14.4 million in Q1 2026.
- Average EBITDA over 4 years is -$4.7 million, with a median of -$4.1 million recorded in 2023.
- Year-over-year, EBITDA plunged 627.12% in 2024 and surged 70.47% in 2025.
- Akari Therapeutics' EBITDA stood at -$4.3 million in 2023, then gained by 17.59% to -$3.6 million in 2024, then slumped by 37.72% to -$4.9 million in 2025, then plunged by 192.56% to -$14.4 million in 2026.
- Business Quant data shows AKTX's EBITDA at -$14.4 million in Q1 2026, -$4.9 million in Q4 2025, and -$6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | -106.00 Mn |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | -14.44 Mn |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 249.90 Mn |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 1.14 Bn |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | -4.91 Mn |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 661.60 Mn |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 394.00 Mn |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 201.19 Mn |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | -445.22 Mn |
| 10 | Moderna | 28.64 Bn | 23.43 Bn | -566.00 Mn | -1.39 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.44 Mn |
| Dec 31, 2025 | -4.94 Mn |
| Sep 30, 2025 | -6.44 Mn |
| Jun 30, 2025 | -2.23 Mn |
| Mar 31, 2025 | -3.74 Mn |
| Dec 31, 2024 | -3.58 Mn |
| Sep 30, 2024 | -3.07 Mn |
| Jun 30, 2024 | -7.55 Mn |
| Mar 31, 2024 | -5.29 Mn |
| Dec 31, 2023 | -4.35 Mn |
| Sep 30, 2023 | -2.87 Mn |
| Jun 30, 2023 | -4.06 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2020 | -6.84 Mn |
| Sep 30, 2020 | 909,778.00 |
| Jun 30, 2020 | -7.49 Mn |
| Mar 31, 2020 | -3.97 Mn |
| Dec 31, 2019 | 53,233.00 |
| Sep 30, 2019 | -2.88 Mn |
| Jun 30, 2019 | -6.11 Mn |